title: [Study on intervention effect of Danggui Shaoyao San on rats with cirrhotic ascites].
abstract: OBJECTIVE
  To investigate the intervention effect of Danggui Shaoyao San on rats with cirrhotic ascites, and discuss the effect of arginine vasopressin (AVP) on cirrhotic ascites.
  
  
  METHODS
  Male SD rats were randomly divided into the control group, the model group, Danggui Shaoyao San low, middle and high dose groups. The cirrhotic ascites rat model was established by CCl4 combined with phenobarbital. Their urines were collected at 24 h to observe urine excretion of each group. Filter papers were used to determine the amount of ascites. The levels of serum alanine aminotransferasa (ALT) , aspartate aminotransferase (AST) were detected by the automatic biochemistry analyzer. Plasma prothrombin time (PT) was evaluated by the blood coagulation analyzer. The concentration of AVP in plasma was detected by enzyme-linked immunosorbent assay (ELISA). Pathological changes in livers were observed by HE staining.
  
  
  RESULTS
  Compared with the model group, the Danggui Shaoyao San group showed significant improvement in live indexes, with notable decrease in serum ALT and AST and the time of PT, improvement in liver pathological changes. Simultaneously, the amount of ascites decreased to varying degrees, with notable increase in urine in 24 h and decrease in AVP concentration in plasma.
  
  
  CONCLUSIONS
  Danggui Shaoyao San can notably improve liver functions of rats with cirrhotic ascites, reduce the generation of ascites and delay the progress of liver pathological changes. Its mechanism may be related to AVP.
authors.affiliation: Provincial Key Laboratory of Modern Chinese Medicine, College of Pharmacy, Anhui University of Traditional Chinese Medicine, Hefei 230031, China. 809327116@qq.com
authors.forename: Cheng-Ye
authors.initials: CY
authors.lastname: Wang
authors.forename: Fan
authors.initials: F
authors.lastname: Xu
authors.forename: Man-Yuan
authors.initials: MY
authors.lastname: Wang
authors.forename: Zi-Hua
authors.initials: ZH
authors.lastname: Xuan
authors.forename: Si-Yao
authors.initials: SY
authors.lastname: Hu
authors.forename: Yu
authors.initials: Y
authors.lastname: Zhou
authors.forename: Jia
authors.initials: J
authors.lastname: Lu
mesh_terms: D000818:Animals; D001127:Arginine Vasopressin / Q000097:blood; D001201:Ascites / Q000097:blood / Q000150:complications* / Q000188:drug therapy* / Q000503:physiopathology; D004365:Drugs, Chinese Herbal / Q000494:pharmacology* / Q000627:therapeutic use; D008099:Liver / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism / Q000503:physiopathology; D008103:Liver Cirrhosis / Q000150:complications*; D008297:Male; D051381:Rats; D017207:Rats, Sprague-Dawley
chemical_list: D004365:Drugs, Chinese Herbal; C531150:danggui-shaoyao-san; D001127:Arginine Vasopressin